Patients with diabetic retinopathy most often delayed treatments due to hospital stays.
Vernal keratoconjunctivitis is a rare allergic eye disease that affects the pediatric population and results in severe inflammation of the surface of the eye.
Researchers show no differences in therapeutic responses across age groups.
Diabetic eye examinations enabled detection and treatment of posterior uveal melanomas at an earlier stage, leading to lower mortality.
Study shows how lesion morphology is associated with rates of recurrence.
Researchers show potential treatment against epithelial defects.
Researchers suggest the susceptibility of extraocular muscle fibers to mito-chondrial DNA deletions vary with fiber type.
Researchers suggest corneal hysteresis may be predictive of glaucomatous vision loss.
IRIS Registry data shows which patients respond to laser trabeculoplasty.
For patients with type 2 diabetes, consumption of green tea and coffee is associated with reduced all-cause mortality.
In an evidence-based clinical guideline, recommendations are presented for the medical care of adults with Down syndrome.
For moderately ill hospitalized patients with COVID-19, tocilizumab is not effective for preventing intubation or death.
Researchers evaluated the subclinical corneas of scleral lens wearers after 3 months.
Researchers share data from the first randomized, double-masked, placebo-controlled trial of atropine 0.01% in mainland China.
Researchers investigate robotic force control applications in retinal surgeries.
Researchers assessed the impact Tocilizumab had on patients with non-infectious uveitis and found that the antibody reduced inflammation in eyes with the disease.
Neuro-ophthalmic findings such as optic neuritis, vision loss, and cranial neuropathies are not common in patients with COVID-19, but several cases exist throughout the literature.
Researchers consider if glaucomatous damage can be accurately diagnosed in patients with high myopia using OCT.
Patients with ERM often close one eye to improve vision, but it can reduce quality of life scores.
After SMILE surgery, patients experience a slower visual recovery than with LASIK, which researchers say is tied to the higher optical densities in the early postoperative period.